X0306 4 2021-02-09 0 0001640428 EverQuote, Inc. EVER 0001744802 Revesz Tomas Jr C/O EVERQUOTE, INC. 210 BROADWAY CAMBRIDGE MA 02139 0 1 0 0 Chief Architect Class A Common Stock 2021-02-09 4 M 0 20000 6.88 A 543894 D Class A Common Stock 2021-02-09 4 S 0 11574 50.45 D 532320 D Class A Common Stock 2021-02-09 4 S 0 7776 51.35 D 524544 D Employee Stock Option (right to buy) 6.88 2021-02-09 4 D 0 20000 0.00 D 2026-01-10 Class B Common Stock 20000 138796 D Employee Stock Option (right to buy) 6.88 2021-02-09 4 A 0 20000 0.00 A 2026-01-10 Class A Common Stock 20000 20000 D Employee Stock Option (right to buy) 6.88 2021-02-09 4 M 0 20000 0.00 D 2026-01-10 Class A Common Stock 20000 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2019 and represent the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 28, 2020. The sales do not represent a discretionary trade by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.96 inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.02 to $51.75, inclusive. The reporting person undertakes to provide to EverQuote, Inc., any security holder of EverQuote, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. The reported transaction involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option with respect to the exercised shares. The original option was granted on January 11, 2016 and originally provided for the purchase of up to an aggregate total of 320,000 shares of Class B Common Stock, with the shares underlying the option scheduled to vest over six years in seventy-two equal monthly installments with the first installment vested on December 31, 2015. The shares underlying the portion of the original option that was cancelled were fully vested and the replacement option was fully vested and exercisable for the number of shares of Class A Common Stock acquired in this transaction. /s/ David Mason, as attorney-in-fact for Tomas Revesz 2021-02-11